Literature DB >> 31533119

Comprehensive Assessment of Kidney Health in Acute Kidney Injury: Can It Be Achieved?

Etienne Macedo1,2, Camila Lima3.   

Abstract

Acute kidney injury (AKI) is a frequent event in hospitalized patients, with an incidence that continues to rise, reaching as high as 70-80% in intensive care settings. The need for dialysis and progression to end-stage kidney disease (ESKD) after an episode of AKI is relatively low, from 5 to 20%. However, it is now recognized that patients with AKI may have very different kidney outcomes, varying from complete recovery, incipient chronic kidney disease (CKD), to progression to ESKD. Recent studies have shown that even mild AKI episodes can be associated with a 90% increased risk of developing CKD during long-term follow-up. There is a significant need to focus our efforts on factors that could mitigate the progression of kidney dysfunction and ultimately improve outcomes from AKI. The first step toward this goal encompasses a better understanding of tubular and glomerular alterations during and following an AKI episode. Our current approach, based solely on glomerular filtration rate (GFR), is flawed, since the loss of kidney function does not correspond to the degree of decline in estimated GFR (eGFR), and eGFR does not reflect tubular function. Changes in tubular concentration, reabsorptive and secretory capacity are recognized in AKI; however, they have not been incorporated in clinical assessments of overall kidney function. Here we review a few candidates to assess glomerular filtration/permeability, tubular dysfunction, and injury and how we expect these markers to alter during the development and recovery phase of AKI.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Biomarkers

Mesh:

Substances:

Year:  2019        PMID: 31533119      PMCID: PMC6821574          DOI: 10.1159/000502381

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  33 in total

1.  Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy.

Authors:  Julie K K Vishram; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Giuseppe Mancia; Peter M Okin; Peter M Rothwell; Kristian Wachtell; Michael H Olsen
Journal:  J Hypertens       Date:  2015-12       Impact factor: 4.844

Review 2.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

Review 3.  Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.

Authors:  Rakesh Malhotra; Edward D Siew
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-08       Impact factor: 8.237

4.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 6.  Uromodulin (Tamm-Horsfall protein): guardian of urinary and systemic homeostasis.

Authors:  Radmila Micanovic; Kaice LaFavers; Pranav S Garimella; Xue-Ru Wu; Tarek M El-Achkar
Journal:  Nephrol Dial Transplant       Date:  2020-01-01       Impact factor: 5.992

7.  Urinary ammonia and long-term outcomes in chronic kidney disease.

Authors:  Marion Vallet; Marie Metzger; Jean-Philippe Haymann; Martin Flamant; Cédric Gauci; Eric Thervet; Jean-Jacques Boffa; François Vrtovsnik; Marc Froissart; Bénédicte Stengel; Pascal Houillier
Journal:  Kidney Int       Date:  2015-03-11       Impact factor: 10.612

Review 8.  Biomarkers in nephrology: Core Curriculum 2013.

Authors:  Gearoid M McMahon; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2013-02-27       Impact factor: 8.860

9.  Tubular Secretion in CKD.

Authors:  Astrid M Suchy-Dicey; Thomas Laha; Andrew Hoofnagle; Rick Newitt; Tammy L Sirich; Timothy W Meyer; Ken E Thummel; N David Yanez; Jonathan Himmelfarb; Noel S Weiss; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

10.  The value of uromodulin as a new serum marker to predict decline in renal function.

Authors:  Andreas Leiherer; Axel Muendlein; Christoph H Saely; Eva M Brandtner; Kathrin Geiger; Peter Fraunberger; Heinz Drexel
Journal:  J Hypertens       Date:  2018-01       Impact factor: 4.844

View more
  1 in total

1.  Resveratrol Plays Protective Roles on Kidney of Uremic Rats via Activating HSP70 Expression.

Authors:  Shandan Feng; Jianjie Wang; Jian Teng; Zhan Fang; Chongting Lin
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.